about
The genetic epidemiology of neurodegenerative disease.DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicitySuperoxide dismutase from the eukaryotic thermophile Alvinella pompejana: structures, stability, mechanism, and insights into amyotrophic lateral sclerosisThe ubiquitin proteasome system in glia and its role in neurodegenerative diseasesSearching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programmeTechniques for Monitoring Protein Misfolding and Aggregation in Vitro and in Living CellsNew application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.Downregulation of MicroRNA-193b-3p Promotes Autophagy and Cell Survival by Targeting TSC1/mTOR Signaling in NSC-34 Cells.TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research.The structural biochemistry of the superoxide dismutases.Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy.Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways.TARDBP mutations are not a frequent cause of ALS in Finnish patients.Quercitrin and quercetin 3-β-d-glucoside as chemical chaperones for the A4V SOD1 ALS-causing mutant.Biomarkers for amyotrophic lateral sclerosis.Physiotherapeutic conduct in amyotrophic lateral sclerosis.Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis.Protein biomarkers for amyotrophic lateral sclerosis.Walking the oxidative stress tightrope: a perspective from the naked mole-rat, the longest-living rodentEffect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: a window of opportunity in the search for genetic modifiers.Does α-amino-β-methylaminopropionic acid (BMAA) play a role in neurodegeneration?Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.Inflammatory role of dendritic cells in Amyotrophic Lateral Sclerosis revealed by an analysis of patients' peripheral blood.Profilin1 biology and its mutation, actin(g) in disease.Improving the Delivery of SOD1 Antisense Oligonucleotides to Motor Neurons Using Calcium Phosphate-Lipid Nanoparticles.Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets.Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis.The IVS1 +319 t>a of SOD1 gene is not an ALS causing mutation.Antisense oligonucleotides in neurological disorders.50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosisA 50 bp deletion in the SOD1 promoter lowers enzyme expression but is not associated with ALS in SwedenCHCHD10 is not a frequent causative gene in Chinese ALS patientsAdipsin, MIP-1b, and IL-8 as CSF Biomarker Panels for ALS Diagnosis
P2860
Q22306301-324F4857-A350-4784-9BE4-72B76FC0335DQ24533845-187EB12B-C573-4782-9361-02BFCC8ECF35Q27312600-F52BAC51-12A5-415D-BA87-359181D68934Q27653085-599B8B6E-75C6-4D6B-88B3-2DED752B7251Q28391948-E64A70F0-B80D-4B1C-A1F6-BA3055827F9DQ28393837-801E2451-7F8A-448F-8E7B-B295D78730DAQ30420104-9FE98102-09F5-4478-B496-F4D3DC614A61Q33338981-B145BCAB-F972-4A12-8081-6E78C6657E04Q33736536-6B154362-6CD4-4FFD-BAAC-A6B02CC52C94Q34131994-804AA35B-F862-426C-A3A2-4CC487E7BC72Q34401653-309D5F03-2C3F-481E-8185-0AC18E3BACE8Q34993111-58E70E7D-9B0D-4FDC-B1E6-28F7BE895F2EQ35958359-CBAEE038-8718-4EFF-BB63-118544F1A79AQ35964723-EC9FA408-E7DF-40BB-964A-D626C61C914AQ36087937-95A3FC5B-D2B4-403C-BF3B-503BC6D1AF83Q36334443-FED31952-A770-49D3-8DD6-A7A7FEBB2DCBQ36364363-807FE4B6-33DC-42C1-ACB0-F06C35AF64D3Q36481118-EA5F9D0B-5494-4A9A-AEB1-66E1208B54A3Q36745426-AE266F77-4F28-4B70-90CC-EFCA680FECE0Q36866600-A042A905-E1EB-45C1-B243-45BB1FDFC220Q37157841-9216EA4F-4C10-49B0-8955-EAC1E930A588Q37693585-B778973E-B140-4DB2-8383-4B8D198CC770Q37829424-CE4A4AFD-6476-4FFD-A969-198B2E245DDDQ37948045-AD14CC23-8174-44F9-9574-A877A1D75E69Q38091029-C84C9226-DD59-42B7-AFD4-DF5ABAC9C415Q38246367-79BDA188-E630-4553-A198-0C71CE05DE39Q38629714-FF2D17E2-AD5E-40FA-997E-AC5ED6F8741AQ38964723-002B174E-EBF4-4E3E-8011-D8CB23426E0BQ41599384-ED5264D6-639B-47F1-909F-E9D293111016Q42730589-44691245-D050-43CA-BB46-43149A5C0C0BQ44735743-7F450353-5D64-4E7F-B4F4-23FC5D2F3A26Q50770851-6AD6365B-2BC8-48BF-A7AC-56EE4596614AQ55018458-FEA738D7-454A-4BC3-9715-9C447B4C9976Q57273767-48FAB485-EC64-42A9-94BC-3F1902F6A472Q58125282-2D4AAC0F-2AA2-427E-8F50-0EA9540F11D3Q58125483-2AB9F00D-3DDD-41AE-8C88-DF4DD8BE9932Q58575478-8DBFB75F-5F2B-4F55-A38E-CC5F6B3E2430
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Genetic epidemiology of amyotrophic lateral sclerosis.
@ast
Genetic epidemiology of amyotrophic lateral sclerosis.
@en
type
label
Genetic epidemiology of amyotrophic lateral sclerosis.
@ast
Genetic epidemiology of amyotrophic lateral sclerosis.
@en
prefLabel
Genetic epidemiology of amyotrophic lateral sclerosis.
@ast
Genetic epidemiology of amyotrophic lateral sclerosis.
@en
P2093
P2860
P1433
P1476
Genetic epidemiology of amyotrophic lateral sclerosis.
@en
P2093
Majoor-Krakauer D
Willems PJ
P2860
P304
P356
10.1046/J.0009-9163.2002.00001.X
P577
2003-02-01T00:00:00Z